臨床試験を検索：Ti02 microfine 12.15% Ti02 pigmentary 3% bisoctrizole 10% [V0096 CR (formula RV3131A-MV1166)]
合計1件
-
Orfagen完了
このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。
スポンサーと協力者
- Comunity pharmacy Lekarne Ptuj
- Olayan-Xefos Family Fund for Breast Cancer Research
- US federal government
- The Norwegian Arthroplasty Register
- Reina Sofia University Hospital
- Santa Barbara Cottage Hospital
- Nanox International Laboratory (Belgique)
- Shanghai High-risk Infants Early Intervention Center
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
- Laura Schanberg
- Biomapas
- UiT The Arctic University of Norway
- Synchrophi Systems Ltd
- Areteia Therapeutics
- Beijing Chuiyangliu Hospital
- Zentrum fur Humangenetik Tuebingen
- NMS Laboratories
- West of England Academic Health Science Network
- Northern Ostrobothnia District Hospital
- Bureau of Health of Ji County
- 全リストを表示
CROs by country
- Contract Research Organizations in Belarus
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Estonia
- Contract Research Organizations in Japan
- Contract Research Organizations in Malawi
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Romania
- Contract Research Organizations in Taiwan
- Contract Research Organizations in United States
- Contract Research Organizations in Venezuela
- CRO list by country